期刊文献+

阻塞性睡眠呼吸暂停对高血压患者血管内皮影响研究 被引量:2

Effect of obstructive sleep apnea syndrome on patients with essential hypertension
原文传递
导出
摘要 目的回顾性分析高血压合并阻塞性睡眠呼吸暂停综合征(OSAS)患者的预后及影响因素。方法对2004年1月至2007年10月江苏省省级机关医院确诊的高血压病患者共168例,通过电话和门诊随访,随访时间中位数35个月。根据多导睡眠仪监测结果分为:高血压合并OSAS(OSAS^+)组和高血压不合并OSAS(OSAS^-)组。所有患者均通过彩色多普勒超声测定肱动脉血流介导的舒张功能(FMD),并测定与高血压预后相关的血清生化指标。随访患者心血管死亡、心绞痛或心肌梗死、脑卒中等事件。结果OSAS^+组患者血清超敏C反应蛋白(hsCRP)水平高于OSAS^-组,(2.49±2.65)mmol/L vs(1.73±1.76)mmol/L(P〈0.05),FMD值低于OSAS^-组,(6.20±3.40)%vs(8.39±3.86)%(P〈0.05)。OSAS^+组患者总事件发生率高于OSAS^-组(28.8%vs 13.7%,P=0.016)。Logistic多因素回归分析显示:FMD主要损伤因素排名首位是0SAs(OR=2.89,P=0.003),其次是血清hsCRP(OR=1.23,P=0.044);FMD、血清hsCRP及尿酸成为高血压患者预后的影响因子(OR=1.7,1.7,3.5,P=0.03,0.00,0.01)。结论OSAS影响高血压患者血管内皮功能,使总的事件(心脑血管原因导致的死亡、心绞痛或心肌梗死和脑卒中)发生率增加。OSAS可能主要通过损伤血管内皮功能间接影响高血压患者的预后。 Objective This retrospective study was conducted to evaluate the prognosis of obstructive sleep apnea syndrome(OSAS) on patients with essential hypertension(EH). Methods Follow-up was made on 168 patients with EH associated with OSAS (OSAS+ group) or not(OSAS- group) according to the examination of polysomnography. In all patients, serum biochemical indicators and flow-mediated dilation (FMD) of the brachial artery high-resolution ultrasound technique were assessed. Cardiovascular events (cardiovascular death, angina pectoris or myocardial infarction, and ischemic stroke) served as outcome variables over a follow-up period of 35 months(median) were evaluated. Results The levels of high sense C reactive protein(hsCRP) and FMD were (2.49±2.65) mmol/L and (6.20±3.40)%in OSAS+ group,and those were (1.73±1.76) mmol/L and (8.39±3.86)% in OSAS- group (P〈0.05,respectively). The rate of cardiovascular evets was higher in OSAS+ group compared with that of OSAS- group (28.8% vs 13.7%, P = 0. 016). By multivariate logistic regression, OSAS and serum hsCRP were the significant ( OR = 2.89, P =0. 003; OR=1.23, P = 0. 044, respectively) independent risk factors for FMD; FMD, serum hsCRP and UA were influential factors for the prognosis of patients with EH ( OR =1.7,1.7,3.5, P = 0. 03,0. 00,0. 01,respectively). Conclusions Patients of EH with OSAS have a higher rate of all events and a further damaged edothelium function,by which OSAS could contribute to the prognosis of EH patients.
出处 《国际呼吸杂志》 2009年第15期929-931,共3页 International Journal of Respiration
基金 江苏省卫生厅科研项目资助(H200731)
关键词 高血压病 阻塞性睡眠呼吸暂停综合征 内皮功能 随访 Essential hypertension Obstructive sleep apnea syndrome Endothelium function Follow-up
  • 相关文献

参考文献7

  • 1Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med, 2000,160: 2289-2295.
  • 2阻塞性睡眠呼吸暂停低通气综合征诊断依据和疗效评定标准暨悬雍垂腭咽成形术适应证(杭州)[J].中华耳鼻咽喉科杂志,2002,37(6):403-404. 被引量:1089
  • 3Hirsch AT. Vascular disease, hypertension, and prevension.. "from endothelium to clinical events". J Am Coll Cardiol, 2003,42:377-379.
  • 4Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C- reactive protein and interletikin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003,107 : 1129-1134.
  • 5Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and elects of losartan. Curt Med Res Opin,2004,20.. 369-379.
  • 6Marin JM, Carrizo SJ, Vincente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365: 1046-1053.
  • 7Yaggi HK, Coneato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med, 2005,353 : 2034-2041.

共引文献1088

同被引文献41

  • 1王赞峰,冯学威,康健.阻塞性睡眠呼吸暂停低通气综合征患者的血管内皮舒张功能[J].中华结核和呼吸杂志,2006,29(11):744-746. 被引量:5
  • 2Lavie P,Ben-Yosef R,Ami-hai ER. Prevalence of sleep apnea syndrome among patients with essential hypertension[J]. American heart journal,1984,108(2):373-6.
  • 3Mart i nez-Garc ~ a MA,Campos-Rodr i guez F,Catal 6 n-Serra P,et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study[J]. Am J RespirCrit Care Med,2012, 186(9):909-16.
  • 4Logan AG,Perlikowskl SM,Mente A,et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension[J]. Journal of hypertension,2001,19 ( 12):2271-7.
  • 5Chobanian AV,Bakris GL, Black HR,et aL The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report[J]. JAMA,2003, 289(19):2560-71.
  • 6Yokoe T,Minoguchi K,Matsuo H,et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure[J]. Circulation,2003,107(8):1129-34.
  • 7Shamsuzzaman AS,Winnieki M,Lanfranehi P,et al. Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Circul ation,2002,105 (21 ):2462-4.
  • 8Kokturk O,Ciftei TU,Mollareeep E,et al. Elevated C-reactive protein levels and increased eardiovaseular risk in patients with obstructive sleep apnea syndrome[J]. International heart journal,2005,46(5): 801-9.
  • 9Bernardo Rodr i guez-Iturbe,Nosratola D Vaziri. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension[J]. Nature Clinical Practice Nephrology, 2006,2(10):582-93.
  • 10Meier-Ewert HK,Ridker PM,Rifai N,et al. Absence of diurnalvariation of C-reactive protein concentrations in healthy human subjects[J]. Clinical Chemistry,2001,47(3):426-30.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部